Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Companies
  4. /
  5. Rodrigo Nel Cordoba, MD, Bogota, Colombia – FDA Inspections
Company
•Colombia

Rodrigo Nel Cordoba, MD, Bogota, Colombia – FDA Inspections

Inspection records and compliance data for Rodrigo Nel Cordoba, MD in Bogota. 1 FDA inspection on record, last inspected June 09, 2010.

Sign in to open in Dashboard
Company Profile

This profile covers Rodrigo Nel Cordoba, MD based in Bogota, Colombia.

FDA Inspection History

FDA inspections
1
OAI
0
VAI
0
NAI
1
Form 483s
0
Warning letters
0

Inspected June 9, 2010.

FDA inspections (1)

DateResultFDA center(s)Insp. #
June 9, 2010NAIHuman Drugs · Bioresearch Monitoring665856
FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Jaime Restrepo, M.D.
Laboratorios Baxter S.A.
Hernan Yupanqui Lozno
Victor Sierra, M.D.
Jose Fernando Molina Restrepo, M.D.
Gregorio Sanchez Vallejo
Laura Giraldo, MD
Dr. Jorge Antonio Piedrahita Olier, MD
Foresight Biotherapeutics
Howard R. Knapp, M.D.
Company Information

Name

Rodrigo Nel Cordoba, MD

FEI Number

3008346569

Address

Carrera 69 # 170-40/70, Bogota, Colombia

Country

Colombia

ID: 5461c340-d48c-4024-8cea-7a0a5d7fff94

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.